SOMATOSTATIN
Varicose Veins
General Hospital of Shenyang Military Regionprotein_peptideDormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Varicose Veins cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
DOBESILIC ACID Oguz Arslanturk | Phase 4 | BB |
Allopurinol Tanta University | Phase 2/3 | B |
Lipitor Tanta University | Phase 2/3 | B |
Same molecule, other indications
SOMATOSTATIN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →